An overview of the medical management of nonmelanoma skin cancer
Treatment of nonmelanoma skin cancer (NMSC) has remained confined to a very singular approach. Surgical procedures represent more than 95% of administered treatments for basal cell carcinoma (BCC). In a prospective study, 34.2% of patients underwent the Mohs surgery, 34.5% underwent simple excision, and 26.7% underwent destruction.1 However, some suggest tailoring treatment to patients’ needs and considering alternative modalities.2 Increasing research into medical therapeutics underscores this shift toward individualized and patient-centered care.
Source: Current Problems in Cancer - Category: Cancer & Oncology Authors: Lauren Metterle, Jeffrey S. Russell, Nishit S. Patel Source Type: research
More News: Basal Cell Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Nonmelanoma Skin Cancer | Skin | Skin Cancer | Study